Loading...
Chemical structure of Hederacolchiside A

GN10462

Hederacolchiside A

Also listed as Pulsatilla saponin D

Hederacolchiside A (catalogue number GN10462) is a research-grade chemical available from LABO Scientific in Israel, CAS registry number 68027-15-6. Molecular formula C47H76O17, molecular weight 913.1. IUPAC name: (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-9-(hydroxymethyl)-10-[(2S,3R,4S,5S)-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid. Supplied in 4 pack sizes, from 1mg at ₪183.55 to 10mM (in 1mL DMSO) at ₪1,252.23; the final price is confirmed on your quote, and the lot certificate of analysis and safety data sheet are emailed with your order confirmation.

ChemicalCAS68027-15-6MW913.1FormulaC47H76O17
CAS number
68027-15-6
Molecular weight
913.1
Formula
C47H76O17
Solubility
≥ 91·3mg/mL in DMSO
InChIKey
SOLICHUQXFAOEP-YDIXZRNLSA-N
Catalogue number
GN10462
Brand
GLPBIO
Computed properties PubChem CID 11650910 · XLogP 2 · TPSA 275 Ų · H-bond donors 10
XLogP
2
TPSA
275 Ų
H-bond donors
10
H-bond acceptors
17
Rotatable bonds
9
Heavy atoms
64

SMILES C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H]([C@]3(C)CO)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)O

Computed descriptors from PubChem (CID 11650910), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.